Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia

Genes Dis. 2023 Jul 16;11(4):101037. doi: 10.1016/j.gendis.2023.06.010. eCollection 2024 Jul.
No abstract available